![Jason Avery](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Jason Avery
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Affitech A/S
![]() Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark.
7
| Extinct | Pharmaceuticals: Major | 7 |
MedImmune Ltd.
![]() MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.
7
| Subsidiary | Biotechnology | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jason Avery tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
VERNALIS | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
AGENUS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
BTG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer | |
University of Cambridge | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Masters Business Admin | |
Fjord Marin AS
![]() Fjord Marin AS Miscellaneous Commercial ServicesCommercial Services Fjord Marin AS provides ship brokerage services. The company was founded in 1994 and is headquartered in Måløy, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
University of Leeds | College/University | Masters Business Admin | |
Verdane Capital Advisors AS
![]() Verdane Capital Advisors AS Investment ManagersFinance Verdane Capital Advisors AS (Verdane Capital Advisors) is a private equity firm founded in 1985 by Birger Nergaard. The firm is headquartered in Oslo with additional offices in Berlin, Copenhagen, Helsinki, London, Munich and Stockholm. | Investment Managers | Private Equity Investor | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
TeamTec AS
![]() TeamTec AS Electrical ProductsProducer Manufacturing TeamTec AS manufactures marine incinerators and stripping ejector equipment. Its products include AVITALIS™ BWTS, Incinerators, Ejectors, Machining & Casting, and Fire-Rated Windows. The company was founded in 1984 and is headquartered in Tvedestrand, Norway. | Electrical Products | Director/Board Member | |
Universität zu Köln | College/University | Doctorate Degree | |
Holmen Industri Invest 1 AS
![]() Holmen Industri Invest 1 AS Financial ConglomeratesFinance Holmen Industri Invest 1 AS is a Norwegian investment company. The private company is based in Oslo, Norway. The CEO of the company is Karl-Erik Staubo. | Financial Conglomerates | Director/Board Member | |
ApaTech Ltd.
![]() ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Medical Specialties | Chairman Human Resources Officer | |
University College London | College/University | Undergraduate Degree | |
Aqua Gen AS
![]() Aqua Gen AS Agricultural Commodities/MillingProcess Industries Aqua Gen AS produces and distributes fertilized eggs of Atlantic salmon and rainbow trout. It is a selective breeding firm which develops, produces and delivers genetic material to the global sea-farming industry. The firm's products include salmon eggs and rainbow trout eggs. The company was founded in 1992 and it is headquartered in Trondheim, Norway. | Agricultural Commodities/Milling | Director/Board Member | |
ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Director/Board Member | |
RWTH Aachen University | College/University | Corporate Officer/Principal | |
University of Bielefeld | College/University | Doctorate Degree | |
BI Norwegian Business School | College/University | Graduate Degree | |
Paro AS | Chairman | ||
TeamTec Invest AS
![]() TeamTec Invest AS Trucks/Construction/Farm MachineryProducer Manufacturing TeamTec Invest AS operates as a holding company with interests in manufacturing of marine equipment. The company was founded in 2005 and is headquartered in Tvedestrand, Norway. | Trucks/Construction/Farm Machinery | Director/Board Member | |
Industriverktøy AS
![]() Industriverktøy AS Metal FabricationProducer Manufacturing Industriverktøy AS manufactures precision plastic mouldings. The company is headquartered in Leksvik, Norway. | Metal Fabrication | Chairman | |
The Bioindustry Association
![]() The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Chairman | |
Uni Targeting Research AS
![]() Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Biotechnology | Director/Board Member | |
Biosergen AS
![]() Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Director/Board Member | |
Opsona Therapeutics Ltd.
![]() Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer | |
Nextera AS
![]() Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
AstraZeneca A/S /Denmark/
![]() AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
APIM Therapeutics AS
![]() APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Director/Board Member | |
Alice Therapeutics, Inc. | Director/Board Member | ||
ExpreS2ion Biotechnologies ApS
![]() ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Biotechnology | Director/Board Member | |
Scanbio Marine Group AS
![]() Scanbio Marine Group AS Agricultural Commodities/MillingProcess Industries Scanbio Marine Group AS engages in the production of animal feed ingredients from fish by-products. It offers fish oil and fishmeal from preserved by-products (silage) and fresh raw materials. The company was founded in 1909 and is headquartered in Trondheim, Norway. | Agricultural Commodities/Milling | Director/Board Member | |
CIRCIO HOLDING ASA | Biotechnology | Director/Board Member Director/Board Member | |
Actigen Ltd.
![]() Actigen Ltd. BiotechnologyHealth Technology Actigen Ltd. provides biological products. The private company is based in Cambridge, UK. | Biotechnology | Chief Executive Officer | |
BioXpress Therapeutics SA
![]() BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Biotechnology | Director/Board Member | |
Zelluna Immunotherapy AS
![]() Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
Cambridge Antibody Technology Group Ltd.
![]() Cambridge Antibody Technology Group Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, Cambridge Antibody Technology Group Ltd. is a holding company that oversees its subsidiaries' research, development, and exploitation of molecular engineering products. The company is based in Cambridge, UK and was founded in 1996. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Apollo Therapeutics LLP
![]() Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | Financial Conglomerates | Chief Executive Officer | |
Apollo Therapeutics Group Ltd.
![]() Apollo Therapeutics Group Ltd. Financial ConglomeratesFinance Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason. | Financial Conglomerates | Chief Executive Officer |
Statistiche
Distribuzione geografica
Norvegia | 20 |
Regno Unito | 14 |
Stati Uniti | 5 |
Svizzera | 5 |
Germania | 5 |
Settori
Health Technology | 24 |
Consumer Services | 8 |
Commercial Services | 7 |
Finance | 6 |
Process Industries | 4 |
Posizioni
Director/Board Member | 64 |
Chairman | 34 |
Corporate Officer/Principal | 31 |
Chief Executive Officer | 21 |
Independent Dir/Board Member | 13 |
Contatti più connessi
Insiders | |
---|---|
Peter Chambré | 23 |
David Chiswell | 23 |
Arne Handeland | 19 |
Keith McCullagh | 16 |
Robert Forbes Burns | 16 |
Achim Kaufhold | 14 |
John Aston | 12 |
Martin Welschof | 12 |
Uwe Bicker | 11 |
Alexander Duncan | 9 |
Richard Mason | 9 |
Diane Mellett | 4 |
Lynn Lester | 3 |
- Borsa valori
- Insiders
- Jason Avery
- Connessioni Società